Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: anakinra

Systemic Juvenile Idiopathic Arthritis

Rayfel Schneider, MBBCh, and Ronald M. Laxer, MDCM  |  May 9, 2012

Changing treatment paradigms in the biologic era

Filed under:Clinical Criteria/GuidelinesConditionsRheumatoid Arthritis Tagged with:AC&RAmerican College of Rheumatology (ACR)anti-inflammatorydrugJIAJuvenile idiopathic arthritismacrophage activation syndromeMethotrexatepatient carePediatricsrheumatologistSteroidstocilizumabTreatment

A Duet of Bone and the Immune System

Christian Beyer, MD, and Georg Schett, MD  |  July 12, 2011

Examining emerging perspectives in osteoimmunology

Filed under:ConditionsOther Rheumatic Conditions Tagged with:Autoimmune diseaseboneDiagnostic CriteriaImmune SystemImmunologyPathogenesis

New Guidance for Rheumatologists who Treat JIA

Kathy Hollimon, Med  |  April 13, 2011

Evidence and consensus-based recommendations reflects current knowledge about initiation of therapy

Filed under:ConditionsOther Rheumatic ConditionsResearch Rheum Tagged with:Juvenile idiopathic arthritisResearchrheumatologistTreatment

ACR Honors Accomplishments in Rheumatology

Richard Quinn  |  December 1, 2010

Rheumatologists and health professionals recognized for their contributions to the field

Filed under:AwardsCareer DevelopmentProfessional TopicsProfilesResearch Rheum Tagged with:AC&RAwardsCareerPatientsResearchTraining

Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  November 1, 2010

Information on New Approvals and Medication Safety

Filed under:Drug Updates Tagged with:ApprovalsDrugsPipeline

The Expanded Role of the Inflammasome in Human Disease

Alexander So, MD, and Borbála Pazár, MD, PhD  |  August 1, 2010

Exploring advances, evaluating what remains to be done

Filed under:ConditionsOther Rheumatic Conditions Tagged with:autoinflammatoryInflammasomeinflammationinflammatory syndromesInterleukinSchnitzler’s syndrome

Aggressive Urate Lowering Needed for Gout

Kathy Holliman  |  July 1, 2010

Patients with gout at increased risk for cardiovascular disease and adverse event

Filed under:Clinical Criteria/GuidelinesConditionsGout and Crystalline Arthritis Tagged with:Cardiovascular diseaseGoutPaintherapyTreatmenturate-lowering therapies

Meet the Model Biologics Policy

From the College  |  July 1, 2010

At its February meeting, the ACR board of directors approved the Model Biologics Policy, which will be used when discussing guidelines and patients’ quality of treatment with health insurance companies.

Filed under:From the CollegePractice SupportQuality Assurance/Improvement Tagged with:BiologicsGuidelinesHealth InsurancepolicyPractice Page

Cochrane Launches Journal Club with RA Article

From the College  |  February 1, 2010

Overview of studies on biologic use kicks off monthly literature review feature

Filed under:Career DevelopmentConditionsEducation & TrainingEducation & TrainingFrom the CollegeProfessional TopicsResearch RheumRheumatoid Arthritis Tagged with:BiologicsCochrane ReviewLiteratureResearch ReviewRheumatoid arthritis

Decoding Autoinflammatory Syndromes

Kathy Holliman  |  January 1, 2010

Understanding the genetic basis of errors of the immune system may provide new opportunities for therapy

Filed under:ConditionsOther Rheumatic Conditions Tagged with:ACR/ARHP Annual MeetingautoinflammatorygeneticsInterleukinsystemic autoinflammatory diseasestumor necrosis factor

  • « Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences